Biohall Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.00 M
as on 16-11-2024
- Company Age 10 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 Cr
as on 16-11-2024
- Revenue 12.40%
(FY 2023)
- Profit -3.68%
(FY 2023)
- Ebitda 62.82%
(FY 2023)
- Net Worth 25.61%
(FY 2023)
- Total Assets 51.35%
(FY 2023)
About Biohall Life Sciences
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.20 Cr.
Anil Singh and Raj Singh serve as directors at the Company.
- CIN/LLPIN
U51101UP2014PTC067844
- Company No.
067844
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biohall Life Sciences Private Limited offer?
Biohall Life Sciences Private Limited offers a wide range of products and services, including Plastic & Glass Labware, Laboratory Glassware, Laboratory Burette, Laboratory Flasks, Mirrors and Glassware, Glass Bottles, Laboratory Bottles.
Who are the key members and board of directors at Biohall Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Singh  | Director | 26-Dec-2014 | Current |
| Raj Singh | Director | 30-Oct-2020 | Current |
Financial Performance of Biohall Life Sciences.
Biohall Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.4% increase. The company also saw a slight decrease in profitability, with a 3.68% decrease in profit. The company's net worth Soared by an impressive increase of 25.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biohall Life Sciences?
In 2023, Biohall Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 27 Jul 2022 | ₹5.25 M | Open |
Axis Bank Limited Creation Date: 25 Feb 2022 | ₹6.75 M | Open |
How Many Employees Work at Biohall Life Sciences?
Unlock and access historical data on people associated with Biohall Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biohall Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biohall Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_303470.webp){kind=small}
